Cetero Research (“Cetero”), headquartered in Cary, North Carolina, is a contract research organization serving the pharmaceutical, generic and biotech drug industries.  The Company supports its customers in their efforts to develop new drugs, test the efficacy of existing drugs and evaluate the effects of compounds through bioanalytical services.  In addition, the Company provides ancillary services including data management, statistics and specialized pre-clinical and clinical studies.  The six Cetero sites served generic and innovative pharmaceutical companies offering research services, state-of-the-art clinical facilities and an extensive library of validated bioanalytical methodologies.  Cetero completed four add-on acquisitions during KRG’s ownership period, including the merger with Specialty Research, Inc., another KRG Fund III platform company.

Date of Realization:  December 2011

Industry Sector:  Life Sciences

Fund: III